PubMed:8829135 / 143-276 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCoin-sentences

    {"project":"LitCoin-sentences","denotations":[{"id":"T2","span":{"begin":0,"end":133},"obj":"Sentence"}],"text":"Nefiracetam is a novel pyrrolidone derivative which attenuates scopolamine-induced learning and post-training consolidation deficits."}

    LitCoin-entities

    {"project":"LitCoin-entities","denotations":[{"id":"179","span":{"begin":0,"end":11},"obj":"ChemicalEntity"},{"id":"180","span":{"begin":23,"end":34},"obj":"ChemicalEntity"},{"id":"181","span":{"begin":63,"end":74},"obj":"ChemicalEntity"},{"id":"182","span":{"begin":83,"end":132},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A5","pred":"db_id","subj":"179","obj":"MESH:C058876"},{"id":"A6","pred":"db_id","subj":"180","obj":"MESH:D011760"},{"id":"A7","pred":"db_id","subj":"181","obj":"MESH:D012601"},{"id":"A8","pred":"db_id","subj":"182","obj":"MESH:D007859"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Nefiracetam is a novel pyrrolidone derivative which attenuates scopolamine-induced learning and post-training consolidation deficits."}

    LitCoin-GeneOrGeneProduct-v0

    {"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T2","span":{"begin":17,"end":22},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":52,"end":62},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":75,"end":82},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":96,"end":100},"obj":"GeneOrGeneProduct"}],"text":"Nefiracetam is a novel pyrrolidone derivative which attenuates scopolamine-induced learning and post-training consolidation deficits."}

    LitCoin-GeneOrGeneProduct-v2

    {"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":17,"end":22},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":96,"end":100},"obj":"GeneOrGeneProduct"}],"text":"Nefiracetam is a novel pyrrolidone derivative which attenuates scopolamine-induced learning and post-training consolidation deficits."}

    LitCoin-MeSH-Disease-2

    {"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T3","span":{"begin":83,"end":132},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"ID:","subj":"T3","obj":"DISEASE"}],"text":"Nefiracetam is a novel pyrrolidone derivative which attenuates scopolamine-induced learning and post-training consolidation deficits."}

    LitCoin-MONDO_bioort2019

    {"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T3","span":{"begin":83,"end":132},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"#label","subj":"T3","obj":"DISEASE"}],"text":"Nefiracetam is a novel pyrrolidone derivative which attenuates scopolamine-induced learning and post-training consolidation deficits."}

    LitCoin-Chemical-MeSH-CHEBI

    {"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T7","span":{"begin":0,"end":11},"obj":"ChemicalEntity"},{"id":"T9","span":{"begin":23,"end":34},"obj":"ChemicalEntity"},{"id":"T10","span":{"begin":63,"end":74},"obj":"ChemicalEntity"}],"attributes":[{"id":"A7","pred":"ID:","subj":"T7","obj":"C058876"},{"id":"A8","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_135004"},{"id":"A9","pred":"ID:","subj":"T9","obj":"D011760"},{"id":"A10","pred":"ID:","subj":"T10","obj":"D012601"},{"id":"A11","pred":"ID:","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_16794"}],"text":"Nefiracetam is a novel pyrrolidone derivative which attenuates scopolamine-induced learning and post-training consolidation deficits."}

    LitCoin-training-merged

    {"project":"LitCoin-training-merged","denotations":[{"id":"T10","span":{"begin":63,"end":74},"obj":"ChemicalEntity"},{"id":"T9","span":{"begin":23,"end":34},"obj":"ChemicalEntity"},{"id":"T7","span":{"begin":0,"end":11},"obj":"ChemicalEntity"},{"id":"T22570","span":{"begin":83,"end":132},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A11","pred":"ID:","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_16794"},{"id":"A10","pred":"ID:","subj":"T10","obj":"D012601"},{"id":"A9","pred":"ID:","subj":"T9","obj":"D011760"},{"id":"A8","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_135004"},{"id":"A7","pred":"ID:","subj":"T7","obj":"C058876"},{"id":"A11048","pred":"#label","subj":"T22570","obj":"DISEASE"}],"text":"Nefiracetam is a novel pyrrolidone derivative which attenuates scopolamine-induced learning and post-training consolidation deficits."}